Inventor
Xin Li
Inventor
Shanghai, CN
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes26%
C07DHeterocyclic compounds26%
C07CAcyclic or carbocyclic compounds11%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,799,521Use of icaritin in preparing medicament for preventing or treating hematocytopenia202010,759,788Pharmaceutical uses of pyridine carboxamide derivatives202010,555,962Use of icaritin in preparing medicament for preventing or treating hematocytopenia202010,532,963Methods for the oxidative dehydrogenation of butene to produce butadiene202010,442,794Processes for preparing pyridine carboxamide derivatives201910,442,793Oxa spiro derivative, preparation method therefor, and applications thereof in medicines201910,364,234Pyridinecarboxamide derivatives, preparation method thereof and pharmaceutical uses thereof201910,259,771Vegetable oil polyol and the preparation method and the application thereof201910,081,629Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof20189,624,176'Method for preparing caprolactam by using a microreactor under lewis acid catalysis'20179,566,277'Methods of using phthalazinone ketone derivatives'20179,546,143'Method for preparing high-quality epoxidized fatty acid ester with micro-reaction device'20179,439,881'Acrylamide compounds and use thereof for inhibiting apoptosis'20169,408,811'Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer'20169,358,227'Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives'20169,273,052'Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof'20169,260,384'Urea compounds and use thereof for inhibiting apoptosis'20169,199,978'Acrylamide compounds and use thereof for inhibiting apoptosis'20158,921,571'Pyrrolysine analogs'20148,901,140'6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof'20148,884,007'Hexenone compounds and medical use thereof'20148,859,587'(2E)-3-phenyl-N-[2,2,2-Trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof'20148,623,861'Method of treating demyelination diseases'20148,362,070'Application of puerarin in the preparation of P2X3 mediated drugs for pain/nervous system diseases'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2020Patents assigned to LI XIN (9)· patent assignee history
2014–2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (7)· patent assignee history
2014–2016Patents assigned to CHINESE PLA GENERAL HOSPITAL (4)· patent assignee history
2014–2016Patents assigned to HU GUOLIANG (4)· patent assignee history
2014–2020Based in Shanghai, CN· patent location history
2014–2016Based in Beijing, CN· patent location history
2017–2019Based in Nanjing, CN· patent location history
2018–2020Patents assigned to Shanghai hengrui pharmaceutical co ltd (5)· patent assignee history
2020Based in Linyi, CN· patent location history
2020Based in Sugar Land, TX, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LI XINself | 9 | 2013–2020 |
| JIANGSU HENGRUI MEDICINE CO | 7 | 2014–2020 |
| Shanghai hengrui pharmaceutical co ltd | 5 | 2018–2020 |
| CHINESE PLA GENERAL HOSPITAL | 4 | 2014–2016 |
| HU GUOLIANG | 4 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Shanghai, CN | 9 | 2014–2020 |
| Beijing, CN | 5 | 2014–2016 |
| Nanjing, CN | 3 | 2017–2019 |
| Linyi, CN | 2 | 2020 |
| Sugar Land, Texas, US | 1 | 2020 |